The focus of recruitment has moved from signing elite talent to stars of the future. It has been funded, often, by the sale ...
20h
Hosted on MSNGuggenheim Initiates Coverage of Compass Therapeutics (CMPX) with Buy RecommendationFintel reports that on February 24, 2025, Guggenheim initiated coverage of Compass Therapeutics (NasdaqCM:CMPX) with a Buy recommendation. Analyst Price Forecast Suggests 266.05% Upside As of February ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results